GlassScriptPhysician profile
Peter J Mohr
NPI 1194747238
$7,365.68
in general payments reported to CMS, 2019-2025
9 companies · $1,048 in 2025
The $1,048 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $548 · 2021: $1,006 · 2022: $1,632 · 2023: $1,601 · 2024: $980 · 2025: $1,048.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,628.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,874.54 | 2019-2025 | Opticross, Avvigo Guidance System, Synergy |
| Medtronic, INC. | $2,728.41 | 2021-2025 | Symplicity G3, Ffrangio, Acist Rxi System |
| Shockwave Medical, INC | $842.14 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $463.57 | 2022-2025 | Impella |
| Abbott Laboratories | $246.94 | 2025 | Dragonfly Opstar, Coroflow |
| Chiesi USA, INC. | $123.41 | 2019 | |
| Teleflex LLC | $34.89 | 2023 | Vascband |
| Philips North America LLC | $28.30 | 2020 | |
| Terumo Medical Corporation | $23.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Mohr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.